For consumers searching for just the right sunblock this summer, the options can be overwhelming.

NICE has published its first guideline on melanoma which aims to reduce the numbers of people dying from the disease, and addresses the wide variations across the country in diagnosis and treatment.

Immune cells that hang around after parasitic skin infection help ward off secondary attack, according to a study in The Journal of Experimental Medicine.

MSD (known as Merck & Co Inc. in the United States and Canada) has announced that the European Commission has granted a marketing authorisation for KEYTRUDA® (pembrolizumab) as monotherapy for...

For the first time, people with psoriasis and psoriatic arthritis can contribute directly to the future of research into these chronic, systemic autoimmune diseases through the National Psoriasis...

The FDA have approved a new drug - sonidegib - for treating locally advanced basal cell carcinoma, an increasingly common cancer that occurs in the top layer of the skin.

The National Institute for Health and Care Excellence (NICE) has issued technology appraisal guidance for CosentyxTM (secukinumab).

One of the most basic yet important surgical skills to keep a patient alive and intact may be closing wounds.

Gemstone Biotherapeutics LLC (Gemstone Bio), a Baltimore-based biotechnology company and pioneer in the field of regenerative medicine, has announced the publication of a peer-reviewed scientific...

Avita Medical Ltd., a medical device company specializing in the treatment of wounds and skin defects, today said a branch of the U.S. Military says the U.S.